Cargando…
Targeting Nuclear Hormone Receptors: PPARα Agonists as Potential Disease-Modifying Drugs for Rheumatoid Arthritis
In recent years, peroxisome proliferator-activated receptors (PPARs) have received growing interest due to the broad spectrum of their biological activities. PPARα, an isoform of PPAR, plays an important role in lipid homeostasis and inflammation, which makes it a potential target for the treatment...
Autores principales: | Shirinsky, Ivan V., Shirinsky, Valery S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134189/ https://www.ncbi.nlm.nih.gov/pubmed/21760804 http://dx.doi.org/10.1155/2011/937843 |
Ejemplares similares
-
H(1)-antihistamines are associated with lower prevalence of radiographic knee osteoarthritis: a cross-sectional analysis of the Osteoarthritis Initiative data
por: Shirinsky, Ivan, et al.
Publicado: (2018) -
Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study
por: Yakovlev, Alexey, et al.
Publicado: (2023) -
Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy
por: Nogueira-Recalde, Uxía, et al.
Publicado: (2019) -
Biochemical and structural basis for the pharmacological inhibition of nuclear hormone receptor PPARγ by inverse agonists
por: Irwin, Sean, et al.
Publicado: (2022) -
Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)